Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

INBX

Inhibrx Biosciences (INBX)

Inhibrx Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INBX
DateTimeSourceHeadlineSymbolCompany
05/26/20224:59PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INBXInhibrx Biosciences Inc
05/26/20224:55PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INBXInhibrx Biosciences Inc
05/26/20224:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INBXInhibrx Biosciences Inc
05/25/20225:25PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INBXInhibrx Biosciences Inc
05/19/20224:05PMPR Newswire (US)Inhibrx Announces Details of Presentation at 2022 ASCO Annual MeetingNASDAQ:INBXInhibrx Biosciences Inc
05/17/20221:05AMTipRanksJMP Securities Remains a Buy on Inhibrx (INBX)NASDAQ:INBXInhibrx Biosciences Inc
05/16/20229:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INBXInhibrx Biosciences Inc
05/16/20229:00AMPR Newswire (US)INBRX-101 Shows Favorable Safety Profile in Patients with Alpha-1 Antitrypsin Deficiency and Demonstrates Potential to Achieve Normal Functional Alpha-1 Antitrypsin Levels with Monthly DosingNASDAQ:INBXInhibrx Biosciences Inc
05/11/202212:47AMTipRanksJMP Securities Thinks Inhibrx’s Stock is Going to RecoverNASDAQ:INBXInhibrx Biosciences Inc
05/09/20224:12PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INBXInhibrx Biosciences Inc
05/09/20224:06PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INBXInhibrx Biosciences Inc
05/09/20224:05PMPR Newswire (US)Inhibrx Reports First Quarter 2022 Financial Results and Recent Corporate HighlightsNASDAQ:INBXInhibrx Biosciences Inc
04/25/20229:05AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INBXInhibrx Biosciences Inc
04/25/20229:00AMPR Newswire (US)Inhibrx Announces Formation of Scientific Advisory Board for INBRX-101NASDAQ:INBXInhibrx Biosciences Inc
04/13/20224:09PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INBXInhibrx Biosciences Inc
04/13/20224:04PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:INBXInhibrx Biosciences Inc
04/11/202212:25AMTipRanksInhibrx (INBX) Receives a Buy from JMP SecuritiesNASDAQ:INBXInhibrx Biosciences Inc
04/05/20224:30PMPR Newswire (US)Inhibrx to Present INBRX-101 Data at ATS 2022 Annual MeetingNASDAQ:INBXInhibrx Biosciences Inc
03/24/20224:05PMPR Newswire (US)Inhibrx Announces Details of Presentations at 2022 AACR Annual MeetingNASDAQ:INBXInhibrx Biosciences Inc
03/03/202210:01AMDow Jones NewsInhibrx Gets FDA Orphan Designation for INBRX-101 in AATDNASDAQ:INBXInhibrx Biosciences Inc
03/03/20229:22AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INBXInhibrx Biosciences Inc
03/03/20229:15AMPR Newswire (US)Inhibrx Receives FDA Orphan-Drug Designation for INBRX-101 for the Treatment of Alpha-1 Antitrypsin DeficiencyNASDAQ:INBXInhibrx Biosciences Inc
03/02/20229:36AMTipRanksLifeSci Capital Keeps a Buy Rating on Inhibrx (INBX)NASDAQ:INBXInhibrx Biosciences Inc
03/02/202212:45AMTipRanksInhibrx (INBX) Gets a Buy Rating from JMP SecuritiesNASDAQ:INBXInhibrx Biosciences Inc
02/28/20224:32PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INBXInhibrx Biosciences Inc
02/28/20224:05PMPR Newswire (US)Inhibrx Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Recent Corporate HighlightsNASDAQ:INBXInhibrx Biosciences Inc
02/22/20229:11AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INBXInhibrx Biosciences Inc
02/22/20229:00AMPR Newswire (US)Inhibrx Announces Amended Loan Agreement with OxfordNASDAQ:INBXInhibrx Biosciences Inc
02/14/20225:26PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:INBXInhibrx Biosciences Inc
02/14/20226:01AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:INBXInhibrx Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:INBX